United States - English - NLM (National Library of Medicine)

affordable pharmaceuticals, llc - sodium sulfate (unii: 0ypr65r21j) (sodium cation - unii:lyr4m0nh37), potassium sulfate (unii: 1k573lc5tv) (potassium cation - unii:295o53k152), magnesium sulfate, unspecified form (unii: de08037sab) (magnesium cation - unii:t6v3lhy838) - sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult and pediatric patients 12 years of age and older. sodium sulfate, potassium sulfate and magnesium sulfate oral solution is contraindicated in the following conditions: - gastrointestinal obstruction or ileus  [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precaution ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in sodium sulfate, potassium sulfate and magnesium sulfate oral solution risk summary there are no available data on sodium sulfate, potassium sulfate and magnesium sulfate oral solution use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproductive studies have not been conducted with sodium sulfate,

United States - English - NLM (National Library of Medicine)

sevene usa - dibasic potassium phosphate (unii: ci71s98n1z) (phosphate ion - unii:nk08v8k8hr), silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4), calcium sulfate anhydrous (unii: e934b3v59h) (calcium cation - unii:2m83c4r6zb), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), sodium phosphate, dibasic, heptahydrate (unii: 70wt22sf4b) (phosphate ion - unii:nk08v8k8hr), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), potassium chloride - colds, headaches, exhaustion, nervousness, skin and digestive issues* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated colds, headaches, exhaustion, nervousness, skin and digestive issues** **c, k, ck & x are homeopathic dilutions.

United States - English - NLM (National Library of Medicine)

native remedies llc - galium aparine (unii: z4b6561488) (galium aparine - unii:z4b6561488), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), potassium sulfate (unii: 1k573lc5tv) (sulfate ion - unii:7is9n8kpmg), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), urtica urens (unii: ihn2nq5of9) (urtica urens - unii:ihn2nq5of9) - galium aparine 3 [hp_x] - reduces skin irritation, blistering and weeping skin uses: homeopathic skin tonic for eczema and other common skin problems.

United States - English - NLM (National Library of Medicine)

native remedies, llc - horse chestnut (unii: 3c18l6rjaz) (horse chestnut - unii:3c18l6rjaz), artemisia cina pre-flowering top (unii: 28m1820act) (artemisia cina pre-flowering top - unii:28m1820act), croton tiglium seed (unii: 0hk2gzk66e) (croton tiglium seed - unii:0hk2gzk66e), fagopyrum esculentum (unii: b10m69172n) (fagopyrum esculentum - unii:b10m69172n), potassium sulfate (unii: 1k573lc5tv) (sulfate ion - unii:7is9n8kpmg), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - relieves anal itching, burning and discomfort uses: homeopathic remedy for the relief of anal itching

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - potassium sulfate (unii: 1k573lc5tv) (sulfate ion - unii:7is9n8kpmg) -

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - potassium sulfate (unii: 1k573lc5tv) (sulfate ion - unii:7is9n8kpmg) -

United States - English - NLM (National Library of Medicine)

braintree laboratories, inc. - sodium sulfate (unii: 0ypr65r21j) (sodium cation - unii:lyr4m0nh37), potassium sulfate (unii: 1k573lc5tv) (potassium cation - unii:295o53k152), magnesium sulfate, unspecified form (unii: de08037sab) (magnesium cation - unii:t6v3lhy838) - sodium sulfate 17.5 g in 1 ml - suprep bowel prep kit is indicated for cleansing of the colon as a preparation for colonoscopy in adult and pediatric patients 12 years of age and older. suprep bowel prep kit is contraindicated in the following conditions: - gastrointestinal obstruction or ileus  [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precaution ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in suprep bowel prep kit risk summary there are no available data on suprep bowel prep kit use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproductive studies have not been conducted with sodium sulfate, potassium sulfate, and magnesium sulfate (suprep bowel prep kit). the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 600 mg - potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. potassium chloride extended-release capsules are contraindicated in patients on amiloride or triamterene. risk summary there are no human data related to use of potassium chloride extended-release capsules during pregnancy and animal reproductive studies have not been conducted. potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm. the background risk for major birth defects and miscarriage in the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectiv

United States - English - NLM (National Library of Medicine)

cardinal health - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 750 mg - potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. potassium chloride extended-release capsules are contraindicated in patients on amiloride or triamterene. risk summary there are no human data related to use of potassium chloride extended-release capsules during pregnancy and animal reproductive studies have not been conducted. potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm. the background risk for major birth defects and miscarriage in the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectivel

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 750 mg - potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. potassium chloride extended-release capsules are contraindicated in patients on amiloride or triamterene. risk summary there are no human data related to use of potassium chloride extended-release capsules during pregnancy and animal reproductive studies have not been conducted. potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm. the background risk for major birth defects and miscarriage in the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectivel